1 BTC
=
- USD
Salarius Pharmaceuticals, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About Salarius Pharmaceuticals, Inc. Common Stock
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Market Statistics
Trading Metrics
How to Buy SLRX
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy SLRX
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesSalarius Pharmaceuticals will rebrand as Decoy Therapeutics in early January 2026, reflecting a strategic pivot to a platform-driven biotechnology company focused on peptide-conjugate therapeutics targeting viral diseases and oncology.
Salarius Pharmaceuticals has regained compliance with Nasdaq's Minimum Bid Price Requirement and announced a planned merger with Decoy Therapeutics, a preclinical biopharmaceutical company focused on peptide conjugate therapeutics.
Salarius Pharmaceuticals announced two animal studies supporting the potential of its drug seclidemstat in inhibiting LSD1, a target in cancer treatment. The company is progressing a clinical study at MD Anderson Cancer Center and planning a merger with Decoy Therapeutics.
The liposarcoma treatment market is driven by a rising global disease burden and growing demand for innovative therapies, including immunotherapies and targeted treatments. The pipeline features 15+ companies and 20+ therapies in various stages of development.
